Avera Research Institute

Sioux Falls, South Dakota 57108

4 studies enrolling now · 44 studies all time

What they study most

Agitation, Alopecia Areata, Alzheimer Disease, Alzheimer's Disease, Anemia, Atrial Fibrillation, Attention Deficit Hyperactivity Disorder, Breast Cancer, Bronchiolitis, COVID-19, COVID-19 Vaccines, CPAP

Studies at this site

• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects — Recruiting now
• Investigations of Reproductive Cancers in Women — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) — Recruiting now
• Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure — Recruiting now
• Sleep for Stroke Management and Recovery Trial — Running, not enrolling
• Understanding the Long-term Impact of COVID on Children and Families — Running, not enrolling
• Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters — Completed
• A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives — Completed
• Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool — Completed
• The Circulating Cell-free Genome Atlas Study — Status unconfirmed
• A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
• An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant — APPROVED_FOR_MARKETING
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
• Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants — Completed
• A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers — Withdrawn before enrolling
• Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol — Status unconfirmed
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder — Completed
• A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia — Withdrawn before enrolling
• A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin — Withdrawn before enrolling
• Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification — Status unconfirmed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women — Completed
• Anti-psychotic Medication (Stable Dose) Weight Loss Study — Withdrawn before enrolling
• Anti-psychotic Medication (New Use) Weight Loss Study — Withdrawn before enrolling
• HORIZON-PFT: Pivotal Fracture Trial — Completed
• Web-based Education to Enhance Fibromyalgia Management — Completed
• Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition — Completed
• The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease — Completed
• A Study to Compare Genetic Variations of IGF-I and IGF-II — Completed
• Effects of Music Intervention on the Brain Development of Preschool Children — Completed
• A Study of Vitamin D in Subjects With Alopecia Areata — Completed
• IVIG - West Nile Encephalitis: Safety and Efficacy — Completed
• A Study to Evaluate Glucose and Insulin Response to Nutralin — Completed
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma — Completed
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed